283 related articles for article (PubMed ID: 16254462)
1. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
[TBL] [Abstract][Full Text] [Related]
2. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
3. CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression.
Li B; Goyal J; Dhar S; Dimri G; Evron E; Sukumar S; Wazer DE; Band V
Cancer Res; 2001 Nov; 61(21):8014-21. PubMed ID: 11691827
[TBL] [Abstract][Full Text] [Related]
4. Downregulation and CpG island hypermethylation of NES1/hK10 gene in the pathogenesis of human gastric cancer.
Huang W; Zhong J; Wu LY; Yu LF; Tian XL; Zhang YF; Li B
Cancer Lett; 2007 Jun; 251(1):78-85. PubMed ID: 17182177
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
6. Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers.
Bharaj BB; Luo LY; Jung K; Stephan C; Diamandis EP
Prostate; 2002 Apr; 51(1):35-41. PubMed ID: 11920956
[TBL] [Abstract][Full Text] [Related]
7. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
9. Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
Luo LY; Grass L; Diamandis EP
Clin Chim Acta; 2003 Nov; 337(1-2):115-26. PubMed ID: 14568187
[TBL] [Abstract][Full Text] [Related]
10. Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Zhang Y; Song H; Miao Y; Wang R; Chen L
Cancer Sci; 2010 Apr; 101(4):934-40. PubMed ID: 20180809
[TBL] [Abstract][Full Text] [Related]
11. NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.
Hu J; Lei H; Fei X; Liang S; Xu H; Qin D; Wang Y; Wu Y; Li B
Sci Rep; 2015 Nov; 5():17426. PubMed ID: 26616394
[TBL] [Abstract][Full Text] [Related]
12. Human kallikrein 10, a predictive marker for breast cancer.
Zhang Y; Bhat I; Zeng M; Jayal G; Wazer DE; Band H; Band V
Biol Chem; 2006 Jun; 387(6):715-21. PubMed ID: 16800732
[TBL] [Abstract][Full Text] [Related]
13. The epigenetic basis for the aberrant expression of kallikreins in human cancers.
Pampalakis G; Diamandis EP; Sotiropoulou G
Biol Chem; 2006 Jun; 387(6):795-9. PubMed ID: 16800742
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines.
Kulasingam V; Diamandis EP
Biol Chem; 2007 Oct; 388(10):1113-9. PubMed ID: 17937626
[TBL] [Abstract][Full Text] [Related]
16. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
Manjegowda MC; Gupta PS; Limaye AM
Gene; 2017 May; 614():65-73. PubMed ID: 28286086
[TBL] [Abstract][Full Text] [Related]
17. KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study.
El Sherbini MA; Mansour AA; Sallam MM; Shaban EA; Shehab ElDin ZA; El-Shalakany AH
J Ovarian Res; 2018 Apr; 11(1):32. PubMed ID: 29690914
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
Shvartsman HS; Lu KH; Lee J; Lillie J; Deavers MT; Clifford S; Wolf JK; Mills GB; Bast RC; Gershenson DM; Schmandt R
Gynecol Oncol; 2003 Jul; 90(1):44-50. PubMed ID: 12821340
[TBL] [Abstract][Full Text] [Related]
19. Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
Yousef GM; White NM; Michael IP; Cho JC; Robb JD; Kurlender L; Khan S; Diamandis EP
Tumour Biol; 2005; 26(5):227-35. PubMed ID: 16103744
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation.
Mhawech P; Benz A; Cerato C; Greloz V; Assaly M; Desmond JC; Koeffler HP; Lodygin D; Hermeking H; Herrmann F; Schwaller J
Mod Pathol; 2005 Mar; 18(3):340-8. PubMed ID: 15257317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
